The European Bioinformatics Institute (EMBL-EBI) has been leading computational biology research since its inception in 1994, with work spanning fundamental methods in sequence analysis, multi-dimensional statistical analysis and data-driven biological discovery, from plant biology to mammalian development and disease.
</p>
<blockquoteclass="float-right medium-4 lead drop-quote show-for-medium"><spanclass='lead icon icon-generic research-color'data-icon='P'></span> Four EMBL papers are among the top 100 most highly cited papers ever.</blockquote>
<blockquoteclass="float-right medium-4 lead drop-quote show-for-medium"><iclass='lead icon icon-generic research-color'data-icon='P'></i> Four EMBL papers are among the top 100 most highly cited papers ever.</blockquote>
<p>We are highly collaborative and interdisciplinary, regularly publishing high-impact works on sequence and structural alignment, genome analysis, basic biological breakthroughs, algorithms and methods of widespread importance.</p>
<p>Located on the Wellcome Genome Campus just south of Cambridge in the UK, EMBL-EBI is at the centre of one of the highest concentrations of technical and scientific expertise in the world. We are part of the <ahref="http://www.embl.de/research/faculty/index.php?dtySt=0">European Molecular Biology Laboratory</a>, which has a well-integrated experimental and computational research programme on its five sites.</p><p> EMBL researchers publish regularly in top-tier journals, with 40% of papers in the top 5% of journals in biochemistry, genetics and molecular biology (2012–2014). Four EMBL papers are among the <ahref="http://www.nature.com/news/the-top-100-papers-1.16224">top 100 most highly cited papers ever</a> – one in the top 10 and two co-authored by EMBL-EBI researchers. </p>
